Ganga Pharmaceuticals
12.00
0.00(0.00%)
Market Cap₹7.10 Cr
PE Ratio488.20
IndustryHealthcare
Company Performance:
1D0.00%
1M0.00%
6M+2.74%
1Y-18.92%
5Y+100.00%
View Company Insightsright
More news about Ganga Pharmaceuticals
05Aug 25
Plutus Capital Management Acquires 7.75% Stake in Ganga Pharmaceuticals Through Warrant Conversion
Plutus Capital Management LLP has acquired a 7.75% stake in Ganga Pharmaceuticals through warrant conversion. The non-promoter entity acquired 3,75,000 shares via preferential allotment on July 17, 2025. This acquisition increased Ganga Pharmaceuticals' equity share capital from Rs. 4,83,65,000 to Rs. 5,91,15,000. Plutus Capital made the necessary disclosures under SEBI regulations on July 31, 2025.
 no imag found
1 Year Returns:-18.92%
Industry Peers
Sun Pharmaceutical
1,878.20
(+0.81%)
Divis Laboratories
6,760.50
(-2.33%)
Torrent Pharmaceuticals
4,405.70
(+0.04%)
Cipla
1,432.10
(-0.32%)
Dr Reddys Laboratories
1,336.70
(+2.54%)
Lupin
2,276.20
(+0.80%)
Mankind Pharma
2,503.00
(+1.66%)
Zydus Life Science
1,011.70
(+2.02%)
Aurobindo Pharma
1,511.80
(+0.06%)
Laurus Labs
1,323.60
(+0.62%)